Non-small cell lung cancer

You have access
Feasibility Study of Sequentially Alternating EGFR-TKIs and Chemotherapy for Patients with Non-small Cell Lung Cancer
YOSHIZUMI TAKEMURA, YUSUKE CHIHARA, YOSHIE MORIMOTO, KEIKO TANIMURA, TATSUYA IMABAYASHI, YURIE SEKO, YOSHIKO KANEKO, KOJI DATE, MIKIO UEDA, TAICHIRO ARIMOTO, YOSHINOBU IWASAKI and KOICHI TAKAYAMA

Anticancer Research April 2018, 38 (4) 2385-2390;
You have access
Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer
WEI-TING CHEN, YING-KAI CHEN, SONG-SHEI LIN and FEI-TING HSU

Anticancer Research April 2018, 38 (4) 2161-2167;
You have access
Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue Sections
YUKI SATO, DAICHI FUJIMOTO, KEIICHIRO UEHARA, HAYATO KAWACHI, KAZUMA NAGATA, ATSUSHI NAKAGAWA, KOJIRO OTSUKA, ICHIRO SAKANOUE, HIROSHI HAMAKAWA, YUTAKA TAKAHASHI, YUKIHIRO IMAI and KEISUKE TOMII

Anticancer Research March 2018, 38 (3) 1401-1405;
You have access
Skin Rash Can Be a Useful Marker for Afatinib Efficacy
SHINGO NASU, HIDEKAZU SUZUKI, TAKAYUKI SHIROYAMA, AYAKO TANAKA, KAORI IWATA, NORIKO RYOTA, YUKI UEDA, SO TAKATA, KENTARO MASUHIRO, SATOMU MORITA, NAOKO MORISHITA, NORIO OKAMOTO and TOMONORI HIRASHIMA

Anticancer Research March 2018, 38 (3) 1783-1788;
You have access
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma
YOUNG WHA KOH, SEONG YONG PARK, SEUNG HYUP HYUN and SU JIN LEE

Anticancer Research February 2018, 38 (2) 1067-1071;
You have access
Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans
CRISTA E. HORTON, MOHAMED KAMAL, MACALL LESLIE, ROY ZHANG, TAKEMI TANAKA and MOHAMMAD RAZAQ

Anticancer Research February 2018, 38 (2) 1073-1076;
You have access
Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung Cancer
YASUHIRO KATO, JUMPEI KASHIMA, KAGEAKI WATANABE, MAKIKO YOMOTA, YOSITAKA ZENKE, YUSUKE OKUMA, YUKIO HOSOMI, AKIHIKO GEMMA, MASAHIRO SEIKE and TATSURU OKAMURA

Anticancer Research February 2018, 38 (2) 1077-1083;
You have access
Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population
ROMINA SLUGA, BEN E.E.M. VAN DEN BORNE, PAUL ROEPMAN, BAS J.M. PETERS, ELISABETH A. KASTELIJN and FRANZ M.N.H. SCHRAMEL

Anticancer Research January 2018, 38 (1) 393-400;
You have access
Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer
SHINKICHI TAKAMORI, GOUJI TOYOKAWA, ISAMU OKAMOTO, KAZUKI TAKADA, FUMIHIKO KINOSHITA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, TAKAKI AKAMINE, NOBUTAKA MUKAE, FUMIHIKO HIRAI, TETSUZO TAGAWA, YOSHINAO ODA, TORU IWAKI, KOJI IIHARA, YOICHI NAKANISHI and YOSHIHIKO MAEHARA

Anticancer Research January 2018, 38 (1) 553-557;
You have access
Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer
YUKI KATAOKA, KATSUYA HIRANO, TOMOKO NARABAYASHI, SATOSHI HARA, DAICHI FUJIMOTO, TAE TANAKA, NORIYUKI EBI, KEISUKE TOMII and HIROSHIGE YOSHIOKA

Anticancer Research January 2018, 38 (1) 559-563;

Main menu

User menu

Search

Non-small cell lung cancer

Pages